Alicyn Magruder, PharmD, BCACP, MSCS


Looking Ahead at MS Treatment and Closing Thoughts on Biosimilars

Jeffrey Cohen, MD; Sarah Anderson, PharmD, NBC-HWC; and Alicyn Magruder, PharmD, BCACP, MSCS, share their final thoughts on the future landscape of clinical MS care in the biosimiliars era. [WATCH TIME: 12 minutes]

Sebastian Palmqvist, MD, PhD


Diagnosing Alzheimer Disease With New Blood Tests in Primary Care Settings: Sebastian Palmqvist, MD, PhD

The associate professor of neuroscience at Lund University in Sweden discussed findings from a study of a new blood test examining biomarkers which demonstrated a high accuracy in identifying Alzheimer disease pathology. [WATCH TIME: 5 minutes]

Dongzhe Hong, PhD


Reassessing the Process of Drug Development for Duchenne Muscular Dystrophy: Dongzhe Hong, PhD

The postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School discussed some of the issues with ensuring timely care access to approved therapies for patients with Duchenne muscular dystrophy. [WATCH TIME: 3 minutes]

Temitayo Oyegbile-Chidi, MD, PhD


Understanding the Role of Sleep in the Emergence of Neurodevelopmental Disorders: Temitayo Oyegbile-Chidi, MD, PhD

The pediatric neurologist at the University of California, Davis, provided perspective on some of the mechanistic links between sleep and neurodevelopmental disorders. [WATCH TIME: 3 minutes]

Michael Okun, MD


Michael Okun, MD: Long-Term Plan for Modifying Neurologic Device Approval System

The executive director of the Norman Fixel Institute for Neurological Diseases gave his call-to-action on how to change the approval system for neurologic devices for rare diseases.

Ronald Gavidia, MD, MS


Increased Risk of Insomnia in Transgender Youths With Mental Health Disorders: Ronald Gavidia, MD, MS

The clinical assistant professor in the division of Sleep Medicine, Department of Neurology, University of Michigan spoke about the associations of mental health with insomnia in transgender youth. [WATCH TIME: 5 minutes]

Beth Stein, MD


Improving Patient Communication in MG

Expert neurologists share thoughts on how to improve patient/physician communication and how listening to the patient needs will aid in managing MG.

Flavia Nelson, MD


Practice Pearls for Management of NMOSD

Experts in neurology discuss immune tolerance as an alternative strategy and share practice pearls for approaching treatment of NMOSD.

Mark Lew, MD


The Need to Find Valuable Parkinson Disease Biomarkers: Mark Lew, MD

The director of the Division of Movement Disorders at the USC Keck School of Medicine discussed the early reactions behind reflex tears as a potential biomarker for Parkinson disease. [WATCH TIME: 2 minutes]

Margaret Park, MD


Future Directions for the Management of Narcolepsy

Margaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide clinical pearls and the future treatment landscape for the management of narcolepsy.v

Mitchell S.V. Elkind, MD, MS, MPhil


Improving Access to Stroke Systems of Care: Mitchell S.V. Elkind, MD, MS, MPhil

The president of the American Heart Association discussed the necessary steps to increase access to systems of care in order to improve health overall, including the integration of telemedicine.

Gustavo Dziewczapolski, PhD


Cure CMD: Benefits of the Biennial SciFam Conference

Rachel Alvarez and Gustavo Dziewczapolski, PhD, of Cure CMD spoke about the benefits of attending the biennial Scientific & Family Conference to learn more about congenital muscle diseases and interact with the patient community.

Dolores Santamaria, MD


The Art of Patient Assessment and Knowledge of Treatment Options in Migraine: Dolores D. Santamaria, MD

The director of the Headache Center at Allegheny Health Network talked about the evolution of migraine treatments and highlighted the importance of personalized medicine for patients living with this disabling condition. [WATCH TIME: 10 minutes]

Matthew Allard


Sleeping Around the Podcast: Living with Narcolepsy & Cataplexy: The Patient's Perspective

Sleeping Around the Podcast is joined by Rachel Nesmith, a patient with narcolepsy, who shares her story of overcoming the burdens and impairments of living with narcolepsy and cataplexy.

Sharyl Martini, MD, PhD


AUPN 2022 Veterans Health Administration Workshop

Glenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]

Harmony Sierens, MD


Finding Positivity Through Adversity in Poststroke Care: Harmony Sierens, MD

The medical director of the Inpatient Rehabilitation Unit at Ascension Genesys Hospital discussed the importance of early intervention, sustained care, and rehabilitation in managing poststroke patients. [WATCH TIME: 4 minutes]

Ellen Mowry, MD


Peers & Perspectives: The Induction vs Escalation Approach to MS and the TREAT-MS Trial

Scott Newsome, DO, and Ellen Mowry, MD, discuss the ongoing TREAT-MS trial and its goals, the importance of the findings for clinical practice in multiple sclerosis, and the ongoing discussion around induction vs escalation in MS treatment. [WATCH TIME: 24 minutes]

Michael Panzara, MD, MPH


Key Takeaways and Future Opportunities for WVE-004: Michael Panzara, MD, MPH

The chief medical officer of Wave Life Sciences outlined the FOCUS-C9 study, which has incorporated feedback from patients with both ALS and FTD, as well as investigators in the research field.

Stephen Cunnane, PhD


Stephen Cunnane, PhD: Evaluating Ketogenics in Brain Energy Rescue

The professor from the Universite de Sherbrooke discusses the use of ketogenic diets and supplements to increase cognition.

Ali Jannati, MD, PhD


Future Research Directions for DCTclock and the Potential to Predict Alzheimer Biomarkers: Ali Jannati, MD, PhD

The manager of Clinical Development-Research at Linus Health discussed potential avenues of research for the DCTclock and expanding its capabilities as a potential detector of cognitive decline. [WATCH TIME: 3 minutes]

Margaret Pericak-Vance, PhD


Building a Large-Scale Database of Genetic Associations to Alzheimer Disease: Margaret Pericak-Vance, PhD

The director of the John P. Hussman Institute for Human Genomics at the University of Miami detailed a new international initiative that expands on the genetic backgrounds of people of Hispanic and African ancestry. [WATCH TIME: 4 minutes]

Christian Agudelo, MD


Expanding Research of Sleep and Cognitive Risks Associated: Christian Agudelo, MD

The Evelyn F. McKnight Neurocognitive Scholar at the University of Miami Miller School of Medicine discussed observing how sleep may impact cognitive decline in different populations.

Kent Pryor, PhD


Evaluating 3K3A-APC in Patients With ALS: Kent Pryor, PhD

The CEO of ZZ Biotech outlined the design of the phase 2 trial of 3KA-APC, which will enroll 16 patients with amyotrophic lateral sclerosis. [WATCH TIME: 4 minutes]

Tyler Titcomb, PhD, RDN, IFMCP


Incorporation of Registered Dietitians in MS Care: Tyler Titcomb, PhD, RDN, IFMCP

The postdoctoral scholar at the University of Iowa commented on why the multiple sclerosis field should lean on registered dietitians to help alleviate symptoms of patients with multiple sclerosis. [WATCH TIME: 2 minutes]

Jordan Acosta, MS


Let’s Get Moving: A Multidisciplinary Approach to Gait Rehabilitation in Multiple Sclerosis

Current research pushes to advance therapeutic possibilities and understand underlying neural mechanisms for gait impairments in individuals with the disease.

Evrim Atas, PhD


Muscular Dystrophy Association: A Hybrid Conference Featuring the Latest Advances in Neuromuscular Research, Therapy, and Clinical Care

The Muscular Dystrophy Association's annual meeting will take place in-person and virtually in Nashville, Tennessee, on March 13-16, with more than 950 in-person attendees and 130 presenters.

Randall Schapiro, MD, FAAN


Future of Cognition in Multiple Sclerosis

Ahmed Obeidat, MD, PhD; Randall Schapiro, MD, FAAN; and Jeffrey Wilken, PhD, share their hopes for the future of multiple sclerosis treatment and discuss unmet needs and novel targets.

John Novak, MD, MS


Previewing ALS Association’s Inaugural Nexus Conference: John Novak, MD, MS

The director of the OhioHealth ALS Clinic and vice chair of the ALS Association Care Services Committee discussed the upcoming ALS Nexus Conference and how themes of the event align with the direction of clinical care. [WATCH TIME: 3 minutes]

© 2024 MJH Life Sciences

All rights reserved.